A detailed history of Nemes Rush Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nemes Rush Group LLC holds 4,135 shares of ABBV stock, worth $704,397. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,135
Previous 3,891 6.27%
Holding current value
$704,397
Previous $667 Million 12.81%
% of portfolio
0.11%
Previous 0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $39,976 - $48,636
244 Added 6.27%
4,135 $753 Million
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $45,663 - $53,324
-295 Reduced 7.05%
3,891 $667 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $15,342 - $17,481
-96 Reduced 2.24%
4,186 $762 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $102,787 - $115,762
-747 Reduced 14.85%
4,282 $664 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $222,160 - $257,182
-1,663 Reduced 24.85%
5,029 $750 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $886,756 - $1.1 Million
6,692 New
6,692 $902 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.